LB To, JP Levesque, KE Herbert - Blood, The Journal of the …, 2011 - ashpublications.org
Abstract Transplantation with 2-5× 106 mobilized CD34+ cells/kg body weight lowers transplantation costs and mortality. Mobilization is most commonly performed with …
AEA Lopez-Girona, D Mendy, T Ito, K Miller, AK Gandhi… - Leukemia, 2012 - nature.com
Thalidomide and the immunomodulatory drug, lenalidomide, are therapeutically active in hematological malignancies. The ubiquitously expressed E3 ligase protein cereblon …
B Balasa, R Yun, NA Belmar, M Fox, DT Chao… - Cancer immunology …, 2015 - Springer
Elotuzumab is a humanized monoclonal antibody specific for signaling lymphocytic activation molecule-F7 (SLAMF7, also known as CS1, CD319, or CRACC) that enhances …
Fibroblast growth factors (FGFs) are a family of pleiotropic factors produced by stromal and parenchymal tumor cells. Even though FGFs have been firstly characterized as angiogenic …
D Ribatti, A Vacca - International journal of molecular sciences, 2018 - mdpi.com
Angiogenesis is a constant hallmark of multiple myeloma (MM) progression and involves direct production of angiogenic cytokines by plasma cells and their induction within the bone …
M Endo, M Nishita, M Fujii, Y Minami - … review of cell and molecular biology, 2015 - Elsevier
Wnt5a is involved in the activation of noncanonical Wnt signaling, including planar cell polarity (PCP) and Wnt-Ca 2+ pathways. The Ror-family of receptor tyrosine kinases is …
I Marech, M Ammendola, C Gadaleta… - World journal of …, 2014 - ncbi.nlm.nih.gov
Mast cells (MCs), located ubiquitously near blood vessels, are descended from CD34+ hematopoietic stem cells. Initially, although their role has been well defined in …
A Ferrucci, M Moschetta, MA Frassanito, S Berardi… - Clinical cancer …, 2014 - AACR
Purpose: The aim of this study was to investigate the angiogenic role of the hepatocyte growth factor (HGF)/cMET pathway and its inhibition in bone marrow endothelial cells (EC) …
A Lamanuzzi, I Saltarella, V Desantis, MA Frassanito… - Oncotarget, 2018 - ncbi.nlm.nih.gov
Abstract The mammalian Target of Rapamycin (mTOR) is an intracellular serine/threonine kinase that mediates intracellular metabolism, cell survival and actin rearrangement. mTOR …